| Description | Mcl-1 Inhibitor 16 (Compound 9), a platinum-based mitochondrial-targeting agent, inhibits Mcl-1 and induces Bax/Bak-dependent apoptosis in cancer cells. This compound exhibits antitumor activity and may be utilized as a monotherapy or in combination with ABT-199 [1]. |
| molecular weight | 637.51 |
| Molecular formula | C25H29Cl2N3Pt |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |